Literature DB >> 11545116

Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion.

J T Keijer1, A C van Rossum, N Wilke, M J van Eenige, M Jerosch-Herold, J G Bronzwaer, C A Visser.   

Abstract

The purpose of the study was to investigate the potential of magnetic resonance imaging (MRI) to assess transmural differences in myocardial perfusion. Contrast-enhanced MRI was performed at rest and during hyperemia in a dog model and in 22 patients with single-vessel coronary artery disease. From MR signal intensity-versus-time curves, three perfusion parameters were derived: maximum myocardial contrast enhancement (MCE), slope, and inverse mean transit time (1/MTT). In dogs, MCE correlated well (r = 0.87, p < 0.00001) with microsphere-assessed myocardial blood flow. In the patients, the subendocardial MCE decreased during hyperemia (0.89 +/- 0.18 vs. 0.74 +/- 0.15, p < 0.003) and was lower in subendocardium than in subepicardium (0.74 +/- 0.15 vs. 0.84 +/- 0.21, p < 0.02). Parameters slope and 1/MTT paralleled MCE. Contrast-enhanced MRI reflects the transmural redistribution of myocardial perfusion during hyperemia. Perfusion abnormalities can be identified most distinctly in subendocardial myocardium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11545116     DOI: 10.3109/10976640009146567

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  8 in total

Review 1.  Myocardial perfusion imaging by cardiac magnetic resonance.

Authors:  Juerg Schwitter
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 2.  Assessment of myocardial ischemia with cardiovascular magnetic resonance.

Authors:  Bobak Heydari; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Prog Cardiovasc Dis       Date:  2011 Nov-Dec       Impact factor: 8.194

3.  Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging.

Authors:  Manish Motwani; Timothy Lockie; John P Greenwood; Sven Plein
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

4.  Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Henry Ooi; Douglas B Sawyer; Mark A Lawson; Marvin W Kronenberg
Journal:  J Card Fail       Date:  2013-10-29       Impact factor: 5.712

5.  Contrast-enhanced adenosine-stress magnetic resonance imaging--feasibility and practicability of a protocol for detection or exclusion of ischemic heart disease in an outpatient setting.

Authors:  P Bernhardt; B Levenson; T Engels; O Strohm
Journal:  Clin Res Cardiol       Date:  2006-07-14       Impact factor: 5.460

Review 6.  Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging.

Authors:  J T Keijer; J J Bax; A C van Rossum; F C Visser; C A Visser
Journal:  Int J Card Imaging       Date:  1997-10

7.  Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2003-11-01

8.  Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Mark A Lawson; Li Wang; Henry Ooi; Douglas B Sawyer; Marvin W Kronenberg
Journal:  J Am Heart Assoc       Date:  2014-08-27       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.